Breaking News
Investing Pro 0
Black Friday SALE: Up to 54% OFF InvestingPro+ CLAIM OFFER
Close

Divi's Laboratories Ltd. (DIVI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3,344.00 +38.60    +1.17%
25/11 - Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE361B01024 
S/N:  DIVISLAB
  • Volume: 385,047
  • Bid/Ask: 3,340.00 / 3,344.00
  • Day's Range: 3,276.00 - 3,347.00
Divi's Labs 3,344.00 +38.60 +1.17%

DIVI Financial Summary

 
A brief financial summary of Divi's Laboratories Ltd. as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Divi's Laboratories Limited reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported sales was INR 22,545.2 million compared to INR 19,606.4 million a year ago. Revenue was INR 23,429.1 million compared to INR 19,966.1 million a year ago. Net income was INR 7,020.1 million compared to INR 5,571.1 million a year ago. Basic earnings per share from continuing operations was INR 26.44 compared to INR 20.99 a year ago. Diluted earnings per share from continuing operations was INR 26.44 compared to INR 20.99 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

DIVI Income Statement

Gross margin TTM 63.27%
Operating margin TTM 36.67%
Net Profit margin TTM 32.81%
Return on Investment TTM 22.73%
 Total Revenue  Net Income
Period Ending: Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021
Total Revenue 18545.4 22545.2 24932.4
Gross Profit 11799.1 14425.6 16616.9
Operating Income 5353.1 7630.4 10203.7
Net Income 4936 7020.1 9022.4

DIVI Balance Sheet

Quick Ratio MRQ 5.66
Current Ratio MRQ 9.22
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 0.03%
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021
Total Assets 135182.6 133747.1
Total Liabilities 13835.8 16465.3
Total Equity 121346.8 117281.8

DIVI Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  0.00%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 19118
Cash From Investing Activities -21949.2
Cash From Financing Activities -5324.4
Net Change in Cash -8155.6
* In Millions of INR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DIVI Comments

Write your thoughts about Divi's Laboratories Ltd.
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Rakesh Soni
Rakesh Soni Nov 24, 2022 11:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy divis target 3600
Pankaj Angra
Pankaj Angra Nov 16, 2022 12:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
3200 target hai abhi bhi only manipulate kar raha hai 1 month se
ashish kothari
ashish kothari Oct 31, 2022 1:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Results should be really bad for Divis Lab looks like with 3200 Target & 200 DMA is around 3246 which havent broken from quite time.
Pankaj Angra
Pankaj Angra Oct 18, 2022 12:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
down day by day to meet target 3200
Pankaj Angra
Pankaj Angra Oct 11, 2022 2:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Divis Target 3200 this expiry
Vansh Gera
Vansh Gera Oct 11, 2022 2:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
how much sure you are ?
Pankaj Angra
Pankaj Angra Oct 11, 2022 2:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
3200 sir
Pradeep Garg
Pradeep Garg Aug 12, 2022 6:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Expiry of August around 3900
Vikash Kumar
Vikash Kumar Aug 12, 2022 6:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sure sir
Jai Narayana
Jai Narayana Jun 05, 2022 9:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Divi Labs 4200 very
Pramod Rathod
Pramod Rathod Jun 05, 2022 9:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why
Hemant Joshi
Hemant Joshi May 31, 2022 11:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
dnt think so ...it might touch 3000
Happy Garg
Happy Garg May 25, 2022 12:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
divis lab target June 4100
Kali Krishna Saha
Kali Krishna Saha Mar 16, 2022 8:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
divis lab target by March expiry 2022
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email